{
  "trial_id": "NCT03785210",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, ECOG performance status, Child-Pugh score, HBV status, HCV status, white blood cell count, absolute neutrophil count, lymphocyte count, platelet count, hemoglobin level, total bilirubin level, aspartate transaminase level, alanine aminotransferase level, creatinine clearance, history of cardiovascular disease, prior treatments, presence of liver cirrhosis, presence of autoimmune disease, history of allergic reactions, history of severe hypersensitivity reactions, prior invasive malignancy, pregnancy status, breastfeeding status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "Child-Pugh score",
        "HBV status",
        "HCV status",
        "white blood cell count",
        "absolute neutrophil count",
        "lymphocyte count",
        "platelet count",
        "hemoglobin level",
        "total bilirubin level",
        "aspartate transaminase level",
        "alanine aminotransferase level",
        "creatinine clearance",
        "history of cardiovascular disease",
        "prior treatments",
        "presence of liver cirrhosis",
        "presence of autoimmune disease",
        "history of allergic reactions",
        "history of severe hypersensitivity reactions",
        "prior invasive malignancy",
        "pregnancy status",
        "breastfeeding status"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Child-Pugh Score, Hepatitis B Virus (HBV) Status, Hepatitis C Virus (HCV) Status, White Blood Cell (WBC) Count, Absolute Neutrophil Count (ANC), Lymphocyte Count, Platelet Count, Hemoglobin (Hgb), Total Bilirubin Level, Aspartate Transaminase (AST) Level, Alanine Aminotransferase (ALT) Level, Creatinine Clearance (CrCl),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Child-Pugh Score",
        "Hepatitis B Virus (HBV) Status",
        "Hepatitis C Virus (HCV) Status",
        "White Blood Cell (WBC) Count",
        "Absolute Neutrophil Count (ANC)",
        "Lymphocyte Count",
        "Platelet Count",
        "Hemoglobin (Hgb)",
        "Total Bilirubin Level",
        "Aspartate Transaminase (AST) Level",
        "Alanine Aminotransferase (ALT) Level",
        "Creatinine Clearance (CrCl)"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Child-Pugh Score, Hepatocellular Carcinoma (HCC) Status, Metastatic Pancreatic Cancer Status, Metastatic Colorectal Cancer Status, Liver Metastasis Status, Prior Sorafenib/Lenvatinib Therapy, Prior Atezolizumab/Bevacizumab Therapy, Prior Systemic Chemotherapy, Eastern Cooperative Oncology Group (ECOG) Performance Status, Hemoglobin, White Blood Cell Count, Absolute Neutrophil Count, Lymphocyte Count, Platelet Count, Total Bilirubin, Aspartate Transaminase, Alanine Aminotransferase, Creatinine Clearance.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Child-Pugh Score",
        "Hepatocellular Carcinoma (HCC) Status",
        "Metastatic Pancreatic Cancer Status",
        "Metastatic Colorectal Cancer Status",
        "Liver Metastasis Status",
        "Prior Sorafenib/Lenvatinib Therapy",
        "Prior Atezolizumab/Bevacizumab Therapy",
        "Prior Systemic Chemotherapy",
        "Eastern Cooperative Oncology Group (ECOG) Performance Status",
        "Hemoglobin",
        "White Blood Cell Count",
        "Absolute Neutrophil Count",
        "Lymphocyte Count",
        "Platelet Count",
        "Total Bilirubin",
        "Aspartate Transaminase",
        "Alanine Aminotransferase",
        "Creatinine Clearance"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, Child-Pugh score, liver cirrhosis status, cancer type (HCC, metastatic pancreatic cancer, metastatic colorectal cancer), prior treatment history (sorafenib/lenvatinib, atezolizumab/bevacizumab, chemotherapy), presence of liver metastases, tumor size, tumor location, number of lesions, lesion accessibility for biopsy, HBV/HCV status, hematological function (WBC, ANC, lymphocyte count, platelet count, hemoglobin), hepatic function (total bilirubin, AST, ALT), renal function (creatinine clearance), cardiovascular disease history, history of autoimmune disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "Child-Pugh score",
        "liver cirrhosis status",
        "cancer type (HCC, metastatic pancreatic cancer, metastatic colorectal cancer)",
        "prior treatment history (sorafenib/lenvatinib, atezolizumab/bevacizumab, chemotherapy)",
        "presence of liver metastases",
        "tumor size",
        "tumor location",
        "number of lesions",
        "lesion accessibility for biopsy",
        "HBV/HCV status",
        "hematological function (WBC, ANC, lymphocyte count, platelet count, hemoglobin)",
        "hepatic function (total bilirubin, AST, ALT)",
        "renal function (creatinine clearance)",
        "cardiovascular disease history",
        "history of autoimmune disease."
      ]
    }
  }
}